Literature DB >> 8498178

Bone mineral normative data in Malmö, Sweden. Comparison with reference data and hip fracture incidence in other ethnic groups.

M K Karlsson1, P Gärdsell, O Johnell, B E Nilsson, K Akesson, K J Obrant.   

Abstract

The bone mineral mass was measured in 324 residents of the city of Malmö, Sweden, by dual energy roentgen absorptiometry (DEXA) using the Lunar DPX equipment--total body, hip, and lumbar vertebrae. The bone mineral content of the wrist was also measured with single photon absorptiometry (SPA) in 88 of the individuals. Weight, height, and vertebral height, as well as body fat, lean body mass, menarcheal age, menopausal age, and hand grip strength were determined. Measurements were compared with reference bone mineral content values from the United States, Japan, and France--also hip fracture incidence was compared. All bone mineral values decreased with age. A good correlation was found between the DEXA technique of total body bone mineral and the forearm SPA values. The bone mineral content was correlated with lean body mass and weight. The Malmö bone mineral content was on the same level as in the United States, but higher than in Japan and France. The comparatively high risk of fragility fractures in the Scandinavian countries compared with most other settings cannot be explained by low bone mass.

Entities:  

Mesh:

Year:  1993        PMID: 8498178     DOI: 10.3109/17453679308994562

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  21 in total

1.  Risk factors for low bone mineral density among a large group of Norwegian women with fractures.

Authors:  L M Omland; G S Tell; S Ofjord; A Skag
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  Bone mineral density of the spine and femur in healthy Saudis.

Authors:  M Salleh M Ardawi; Abdulraouf A Maimany; Talal M Bahksh; Hasan A N Nasrat; Waleed A Milaat; Raja M Al-Raddadi
Journal:  Osteoporos Int       Date:  2004-05-27       Impact factor: 4.507

3.  Bone mineral density in Norwegian premenopausal women.

Authors:  Elin Kolle; Monica Klungland Torstveit; Jorunn Sundgot-Borgen
Journal:  Osteoporos Int       Date:  2004-10-21       Impact factor: 4.507

4.  Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis.

Authors:  M Lunt; D Felsenberg; J Adams; L Benevolenskaya; J Cannata; J Dequeker; C Dodenhof; J A Falch; O Johnell; K T Khaw; P Masaryk; H Pols; G Poor; D Reid; C Scheidt-Nave; K Weber; A J Silman; J Reeve
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Effects of pregnancy and lactation on bone mineral density, and their relation to the serum calcium, phosphorus, calcitonin and parathyroid hormone levels in rats.

Authors:  E Gonen; I Sahin; M Ozbek; E Kovalak; S Yologlu; Y Ates
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

6.  Epidemiology of osteoporosis in Korea.

Authors:  S M Rowe; S T Jung; J Y Lee
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Age-related changes of whole skeleton and body composition in healthy men.

Authors:  R Nuti; G Martini; C Gennari
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

8.  Prevalence of osteoporosis and incidence of hip fracture in women--secular trends over 30 years.

Authors:  Henrik G Ahlborg; Björn E Rosengren; Teppo L N Järvinen; Cecilia Rogmark; Jan-Ake Nilsson; Ingemar Sernbo; Magnus K Karlsson
Journal:  BMC Musculoskelet Disord       Date:  2010-03-11       Impact factor: 2.362

9.  Bone mineral density and incidence of hip fracture in Swedish urban and rural women 1987-2002.

Authors:  Björn E Rosengren; Henrik G Ahlborg; Per Gärdsell; Ingemar Sernbo; Robin M Daly; Jan-Ake Nilsson; Magnus K Karlsson
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

10.  Individuals who sustain nonosteoporotic fractures continue to also sustain fragility fractures.

Authors:  M K Karlsson; R Hasserius; K J Obrant
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.